Skip to content

Standardised stroke risk assessment for patients with migrainous symptoms reviewed as suspected TIA (transient ischemic attack)

Standardised stroke risk assessment for patients with MigrAinous symptoms Reviewed as suspected TIA

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN16775533
Enrollment
2709
Registered
2024-11-13
Start date
2024-11-18
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suspected TIA or migraine. Nervous System Diseases

Interventions

This research project is an observational cohort study involving patients with symptoms which could be caused by both TIA and migraine. At study entry, data will be collected about presenting symptoms

Sponsors

Northumbria Healthcare NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Adults with migrainous symptoms reviewed as suspected TIA by a TIA/stroke service 2. Initial review conducted within 1 week of last symptoms 3. Following initial review, a specialist clinician symptom-based diagnosis is either possible migraine or possible TIA with migrainous symptoms 4. At least 40 years old 5. Able to provide informed research consent

Exclusion criteria

Exclusion criteria: 1. Suspected/confirmed TIA without any migrainous features 2. Clear alternative diagnoses after initial review (e.g., seizures) 3. Previous stroke 4. Referral already made or planned for surgical intervention to prevent stroke (e.g., carotid endarterectomy or atrial septal defect closure) 5. Currently under secondary care review for the same neurological symptoms 6. Cognitive difficulties preventing consent and/or description of subjective symptoms 7. Life expectancy <90 days 8. Study day 90 follow-up is not possible (e.g., resident outside of the service boundary)

Design outcomes

Primary

MeasureTime frame
Stroke occurrence determined from medical record information and independent adjudication at 90 days

Secondary

MeasureTime frame
Clinical features, investigations and treatments determined from medical record information at baseline

Countries

England, United Kingdom

Contacts

Public ContactLisa;Chris Shaw;Price

;

lisa.shaw@newcastle.ac.uk;c.i.m.price@newcastle.ac.uk-;-

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026